Antidepressant Reboxetine ineffective: Review By Dr Ananya Mandal cognitive enhancement.

Antidepressant Reboxetine ineffective: Review By Dr Ananya Mandal, MD According to a new research, an antidepressant prescribed over the last 13 years can be ineffective and potentially harmful cognitive enhancement . The drug involved is called Reboxetine and is available beneath the name of Edronax. The analysis showed that it works no much better than a placebo. The study appeared in the British Medical Journal. Manufacturer Pfizer can be accused of failing woefully to disclose the results of trials which present its inadequacies. In UK the licensing authorities and Nice, the National Institute for Health insurance and Clinical Excellence are now looking at the drug again.

Antibiotic for plague authorized by the FDA A plague outbreak can be hugely deadly, so much so that officials warn it can be found in a bioterror attack. U Now.S regulators have approved use of a robust Johnson & Johnson antibiotic to take care of and prevent the extremely rare but potentially deadly infection. PICTURES: Tsunami: 10 health threats that could arrive next Researchers crack genetic code of Dark Death germ, Yersinia pestis The U.S. Meals and Drug Administration also authorized Levaquin, known as levofloxacin generically, to reduce threat of people getting plague after exposure to the bacteria that triggers it, known as Yersinia pestis.

Related Articles

Other Articles from "nephrology":